Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Key Entrepreneurs to Present at 2022 Bioelectronic Medicine Forum

NEW YORK, N.Y. -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that founders and CEOs of several promising bioelectronic medicine startups will present at the Fifth Annual Bioelectric Medicine Forum on April 5, 2022. The event will take place in New York City, although participation via Zoom videoconference will be accommodated.

Entrepreneur presenters at the conference include Attila Borbath, CEO of Synergia Medical, a European firm developing an optical vagus nerve stimulation system, Nicolas Vachicouras, CEO of Neurosoft Bioelectronics, Jennifer Ernst, CEO of Tivic Health, Manfred Franke, CEO of Neuronoff Inc., and Anuj Bhardwaj, CEO of SecondWave Systems Inc.

Peter Staats, a bioelectronic medicine pioneer and co-founder and chief medical officer of electroCore Medical, will keynote the conference. Dr. Staats is internationally recognized for his work in developing and implementing minimally invasive procedures for a number of disorders, including COVID, and his patents have led to the use of novel pharmacologic agents. He is a past President of the North American Neuromodulation Society, American Society of Interventional Pain Physicians, New Jersey Society of Interventional Pain Physicians, and the Southern Pain Society.

Other speakers at the 2022 event include Marom Biksom, professor of biomedical engineering at City College of New York, Imran Eba, partner at Action Potential Venture Capital, Chihiro Hosoya, head of venture management and business development at Astellas Pharma, Eric Hudak, program director at the National Institutes of Health, and Hannah Claridge from TTP plc in the U.K.

Other sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties.

MST is the Platinum Sponsor of this year's event, while Valtronic is the Silver Sponsor.

Key topics will include promising new indications, alliances with bio/pharm firms, regulatory and reimbursement issues, and pricing/commercialization issues.

"Bioelectronic medicine is one of the most promising new segments of the healthcare industry," said James Cavuoto, editor and publisher at Neurotech Reports. "This fifth-annual conference will be a key meeting place for entrepreneurs and executives helping to found this industry."

For more information on the 2022 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link:


Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Books and Publishing, Business, Free News Articles, Product Launches

Neurotech Reports Announces Launch of New Publication Serving Bioelectronic Medicine Industry

SAN FRANCISCO, Calif. -- Neurotech Reports, the San Francisco, California publisher of market intelligence for the healthcare industry, announced the launch of a new monthly newsletter covering the bioelectronic medicine industry, one of the newest and fastest growing industry segments. The publication, BioElectRx Business Report, is the first industry newsletter devoted to bioelectronic medicine, which refers to the therapeutic use of electrical or other forms of stimulation, rather than drugs, to treat disorders.

The publication was introduced at the Neurotech Leaders Forum, which takes place November 8-9, 2021 in San Francisco.

James Cavuoto, editor and publisher at Neurotech Reports, said that bioelectronic medicine promises to alter fundamentally the nature of therapeutic interventions for treating a wide variety of conditions, ranging from inflammatory disorders to bowel and bladder disorders, and a host of other potential markets in which drug therapies have fallen short. "We plan to be the most up-to-date and authoritative source of information and analysis of the market, the major players, deal activity, and important clinical research in bioelectronic medicine," he said.

Cavuoto is the lead author of Neurotech Report's market research study, "The Market for Bioelectronic Medicine: 2022-2027." Neurotech Reports launched the Bioelectronic Medicine Forum in New York City in 2018, and plans to return to New York for the fifth annual event in April 2022.

Helping launch the new publication is consulting editor Susan Schaeffer, former editor of BioCentury, the leading industry newsletter for the pharmaceutical industry. In that role, she advanced new thinking in clinical trial development, regulation, pricing, and market access-factors that will be critical in bioelectronic medicine. She is also a member of the National Academies Forum on Drug Discovery, Development, and Translation and founder of a patient education nonprofit.

"Bioelectronic medicine is rapidly bringing a new modality forward for targeted and personalized medicine-a space that has been dominated by biopharmaceutical companies," said Schaeffer. "BioElectRx Business Report will have a particular focus on the potential for collaboration between these historically separate sectors, and will shed light on the potential of this new technology to treat serious diseases, either without, or in conjunction with drugs."

Contributing editor Jo Jo Platt, who has worked with many bioelectronic medicine pioneers during her career, will round out the editorial team for BioElectRx Business Report.

For more information on subscribing to BioElectRx Business Report, contact Neurotech Reports at 1-415-546-1259, or visit:

For more information on Neurotech Reports, visit:

Learn more about the Neurotech Leaders Forum at:

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Advertising and Marketing, Business, Free News Articles, Reports and Studies, Surgery and Neurotechnology

New Market Research Report on Bioelectronic Medicine Forecasts $16.6B Market

SAN FRANCISCO, Calif. -- A newly published market research report from Neurotech Reports, the leading market intelligence firm in the neurotechnology industry, forecasts that the worldwide market for bioelectronic medicine and related technologies will reach $16.6 billion by 2025. "The Market for Bioelectronic Medicine: 2020-2025" takes an in-depth look at the technology, markets, competitors, research, and growth rates in key application areas in the years 2020 through 2025.

"Bioelectronic medicine represents one of the most promising areas of healthcare and medical technology," said James Cavuoto, editor and publisher of Neurotech Reports. "Our team of editors and market research forecasters has more experience and expertise in this area than any other market intelligence organization."

The research report forecasts U.S. and worldwide revenue, compound annual growth rates, and competitor market shares for bioelectronic medicine devices in several key indications, including inflammatory disorders, hypertension, gastrointestinal disorders, urological disorders, cardiac disorders, metabolic disorders, and ENT disorders. It features in-depth profiles of established and startup bioelectronic medicine firms and key research institutions developing new bioelectronic and neuromodulation therapies.

A unique feature of this report is that it breaks down U.S. and worldwide revenue between core applications that conform to a classic definition of bioelectronic medicine-neuromodulation that affects an end organ-and applications that conform to an expanded definition that includes neuromodulation for neurological disorders. Also highlighted in the report is detailed information on key private and public funding agencies and venture capital firms that are investing in this space.

Authors of the report include Neurotech Reports editors James Cavuoto, Jennifer French, Jeremy Koff, and Margot Puerta. Puerta is the former editor of the journal Bioelectronic Medicine. A team of prominent industry experts also contributed valuable input to the study including Tony Arnold, principal of the consulting firm Precys and former CEO of SetPoint Medical, and Victor Pikov, CEO of Medipace Inc. and former research platforms director at Galvani Bioelectronics.

The report is available through the Neurotech Reports website:

About Neurotech Reports:

Neurotech Reports is the leading source of news and analysis specific to the neurotechnology industry. The firm publishes the monthly newsletter Neurotech Business Report, and also produces two annual investment conferences: the Neurotech Leaders Forum, now in its 19th year, and the Bioelectronic Medicine Forum, now in its second year. Neurotech Reports also offers strategic consulting services to commercial firms and research organizations in neuromodulation and bioelectronic medicine. Learn more at:

*VIDEO: Neurotech Reports editor James Cavuoto offered an overview of the report at the 2019 Bioelectronic Medicine Forum in New York -

*IMAGE link for media:
*Caption: "The Market for Bioelectronic Medicine: 2020-2025" examines core applications involving neuromodulation that affects an end organ, but also forecasts the market in an expanded definition that includes more traditional forms of neuromodulation.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Funding and Investment, Surgery and Neurotechnology

Neurotech Reports Announces 2018 Investment and Management Conference for Bioelectronic Medicine

NEW YORK, N.Y. -- Neurotech Reports, the publisher of Neurotech Business Report newsletter, today announced the launch of the Bioelectronic Medicine Forum, the first investment and management conference for the bioelectronic medicine industry. The inaugural event will take place on March 22, 2018 at the Millennium Broadway Times Square in New York, N.Y.

Featured speakers include Gene Civillico, Ph.D., the Program Manager for the National Institute of Health's SPARC program. Also presenting is Eric Van Gieson, Ph.D., Program Manager at DARPA's Biological Technologies Office, which oversees the ElectRx program. These two U.S. government programs have funded much of the early research into bioelectronic medicine.

Sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as implanted vagus nerve stimulation systems to treat hypertension, and surface stimulation devices to treat a range of disorders.

Several early-stage and emerging bioelectronic medicine firms will be presenting at the conference. These include NeuSpera Medical, which is developing a unique mid-field power technology that uses the body as a waveguide to power bioelectronic devices. Also presenting is Axion Biosystems, a manufacturer of multi-well microelectronic electrode arrays, and Neuroelectrics, a Spanish firm that manufactures noninvasive stimulation and recording devices.

The conference is co-sponsored by the Feinstein Institute for Medical Research. Imran Eba of Action Potential Venture Capital, GSK's venture arm in bioelectronic medicine, will serve as a moderator. The event takes place in the same venue and one day prior to the Future Leaders Conference, which is produced and organized by BioCentury, a global leader in business intelligence for the biopharma industry. BioCentury is pleased to serve as a marketing partner of the Bioelectronic Medicine Forum.

"Bioelectronic medicine represents one of the fastest growing segments of the life sciences industry. Participants at the 2018 Bioelectronic Medicine Forum will have an opportunity to help shape the future of this exciting field," said James Cavuoto, editor and Publisher of Neurotech Business Report.

For more information, contact James Cavuoto at 415-546-1259 or visit .


Related link:

This news story was published by the Neotrope® News Network - all rights reserved.